Semaglutide, the weight management drug sold as Ozempic and Wegovy, may reduce the risk of Alzheimer's disease by 40% to 70% ...

For years, scientists have observed a connection between type 2 diabetes and an increased risk of dementia, particularly ...

Alzheimer's disease (AD) is a progressive brain disorder that gradually destroys memory and cognitive abilities, affecting ...

A new study reveals that the active ingredient in drugs like Ozempic and Wegovy could lower the risk of developing ...

Researchers found a significant reduction in the risk for a first-time AD diagnosis in association with semaglutide.

Compared to other anti-diabetic drugs, semaglutide, also known as Ozempic, may lower the risk of Alzheimer’s disease in ...

Nearly 7 million Americans 65 and older are living with Alzheimer’s disease, which gradually destroys memory and thinking ...

The active ingredient in Ozempic was associated with a 40% to 70% lower risk of a first-time Alzheimer’s diagnosis in ...

Share on PinterestMore evidence suggests that semaglutide drugs could help lower the risk of Alzheimer’s disease. Image ...

Could the drug that's changing the weight loss industry also protect older adults against the most common form of dementia?

Researchers use real-world data in the United States to evaluate the protective role of semaglutide against Alzherimer’s ...

It’s the active ingredient in Novo Nordisk’s Ozempic and Wegovy; Study done in comparison of seven popular diabetes medicines ...